The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Induction of xenobiotic enzymes by the map kinase pathway and the antioxidant or electrophile response element (ARE/EpRE),†,‡
Abstract
Cellular responses to xenobiotic-induced stress can signal proliferation, differentiation, homeostasis, apoptosis, or necrosis. To better understand the underlying molecular mechanisms after exposure to xenobiotics or drugs, we studied the signal transduction pathways, the mitogen-activated protein kinase (MAPK), and the basic leucine zipper transcription factor Nrf2, activated by different agents in the induction of Phase II drug metabolizing enzymes (DMEs). The MAPKs, characterized as proline-directed serine/threonine kinases, are essential components of signaling pathways that convert various extracellular signals into intracellular responses through serial phosphorylation cascades. Once activated, MAPKs can phosphorylate many transcription factors, such as c-Jun, ATF-2, and ultimately lead to changes in gene expression. Two classes of Phase II gene inducers, which are also cancer chemopreventive agents, were studied: (1) the phenolic antioxidants, namely butylated hydroxyanisole (BHA) and its active de-methylated metabolite t-butylhydroquinone (tBHQ), and phenolic flavonoids such as green tea polyphenols (GTP) and (-)-epigallocatechin-3-gallate (EGCG); and (2) the naturally occurring isothiocyanates, namely phenethyl isothiocyanate (PEITC), and sulforaphane. BHA and tBHQ are both well-known phenolic antioxidants used as food preservatives, and strongly activate c-Jun N-terminal kinase 1 (JNK1), extracellular signal-regulated protein kinase 2 (ERK2), or p38, in a time- and dose-dependent fashion. Free radical scavengers N-acetyl-L-cysteine (NAC), or glutathione (GSH), inhibited ERK2 activation and, to a much lesser extent, JNK1 activation by BHA/tBHQ, implicating the role of oxidative stress. Under conditions where MAPKs were activated, BHA or GTP also activated ARE/EpRE (antioxidant/electrophile response element), with the induction of Phase II genes such as NQO. Transfection studies with various cDNAs encoding wild-type or dominant-negative mutants of MAPKs and/or transcription factor Nrf2, substantially modulated ARE-mediated luciferase reporter activity in the presence or absence of phenolic compounds. Other phytochemicals including PEITC, and sulforaphane, also differentially regulated the activities of MAPKs, Nrf2, and ARE-mediated luciferase reporter gene activity and Phase II enzyme induction. A model is proposed where these xenobiotics (BHA, tBHQ, GTP, EGCG, PEITC, sulforaphane) activate the MAPK pathway via an electrophilic-mediated stress response, leading to the transcription activation of Nrf2/Maf heterodimers on ARE/EpRE enhancers, with the subsequent induction of cellular defense/detoxifying genes including Phase II DMEs, which may protect the cells against toxic environmental insults and thereby enhance cell survival. The studies of these signaling pathways may yield insights into the fate of cells upon exposure to xenobiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634 · cited 1×
“Most recently, a cytosolic protein, Keap1, has been proposed to suppress the transcriptional activity of Nrf2 by retaining Nrf2 in the cytoplasm (41).”
BackgroundActivation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases
Karin, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16483 · Cited by 2,431
Cobb, M. H., & Goldsmith, E. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.14843 · Cited by 1,719
Role of Quinones in Toxicology
Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., & Monks, T. J. (2000) · Chemical Research in Toxicology · doi:10.1021/tx9902082 · Cited by 1,703
Zhang, Y., Talalay, P., Cho, C. G., & Posner, G. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2399 · Cited by 1,682
NELSON, D. R., KAMATAKI, T., WAXMAN, D. J., GUENGERICH, F. P., ESTABROOK, R. W., FEYEREISEN, R., GONZALEZ, F. J., COON, M. J., GUNSALUS, I. C., GOTOH, O., et al. (1993) · DNA and Cell Biology · doi:10.1089/dna.1993.12.1 · Cited by 1,655
Moi, P., Chan, K., Asunis, I., Cao, A., & Kan, Y. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9926 · Cited by 1,607 · cited 2×
“Kan, USCF (69)] occurred with ARE-LUC reporter construct, the transcriptional activation of ARE-LUC reporter gene being induced in a dose-dependent manner (70).”
BackgroundP450 GENES: STRUCTURE, EVOLUTION, AND REGULATION
Nebert, D. W., & Gonzalez, F. J. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004501 · Cited by 1,585
An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway
Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee, D. D., Oliver, B. B., Willson, T. M., Zetterström, R. H., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80900-9 · Cited by 1,539
Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease
Tukey, R. H., & Strassburg, C. P. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.581 · Cited by 1,523
Rushmore, T. H., Morton, M. R., & Pickett, C. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99004-6 · Cited by 1,464
Nrf2, a Cap'n'Collar Transcription Factor, Regulates Induction of the Heme Oxygenase-1 Gene
Alam, J., Stewart, D., Touchard, C., Boinapally, S., Choi, A. M. K., & Cook, J. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26071 · Cited by 1,285
Mackenzie, P. I., Owens, I. S., Burchell, B., Bock, K. W., Bairoch, A., Belanger, A., Gigleux, S. F., Green, M., Hum, D. W., Iyanagi, T., et al. (1997) · Pharmacogenetics · doi:10.1097/00008571-199708000-00001 · Cited by 1,183
Venugopal, R., & Jaiswal, A. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14960 · Cited by 1,040
The PAS Superfamily: Sensors of Environmental and Developmental Signals
Gu, Y.-Z., Hogenesch, J. B., & Bradfield, C. A. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.519 · Cited by 1,029
Parallel signal processing among mammalian MAPKs
Cano, E., & Mahadevan, L. C. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)88978-1 · Cited by 1,007
MAP kinase kinase kinase, MAP kinase kinase and MAP kinase
Marshall, C. J. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90095-7 · Cited by 999
Waxman, D. J. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1351 · Cited by 753
Protein kinase cascades activated by stress and inflammatory cytokines
Kyriakis, J. M., & Avruch, J. (1996) · BioEssays · doi:10.1002/bies.950180708 · Cited by 709
Functional antioxidant responsive elements
Wasserman, W. W., & Fahl, W. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5361 · Cited by 705
Honkakoski, P., Zelko, I., Sueyoshi, T., & Negishi, M. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5652 · Cited by 700
The Repressed Nuclear Receptor CAR Responds to Phenobarbital in Activating the Human CYP2B6 Gene
Sueyoshi, T., Kawamoto, T., Zelko, I., Honkakoski, P., & Negishi, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6043 · Cited by 668
The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism
Wei, P., Zhang, J., Egan-Hafley, M., Liang, S., & Moore, D. D. (2000) · Nature · doi:10.1038/35038112 · Cited by 654
Regulation of γ-Glutamylcysteine Synthetase Subunit Gene Expression by the Transcription Factor Nrf2
Wild, A. C., Moinova, H. R., & Mulcahy, R. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33627 · Cited by 597
Nrf2 is essential for protection against acute pulmonary injury in mice
Chan, K., & Kan, Y. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12731 · Cited by 574
Rushmore, T. H., & Pickett, C. B. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77351-1 · Cited by 521
Orphan Nuclear Receptors: Shifting Endocrinology into Reverse
Kliewer, S. A., Lehmann, J. M., & Willson, T. M. (1999) · Science · doi:10.1126/science.284.5415.757 · Cited by 499
Friling, R. S., Bensimon, A., Tichauer, Y., & Daniel, V (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6258 · Cited by 475
Alvarez, E., Northwood, I. C., Gonzalez, F. A., Latour, D. A., Seth, A., Abate, C., Curran, T., & Davis, R. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98613-8 · Cited by 472
Pinkus, R., Weiner, L. M., & Daniel, V. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13422 · Cited by 460
Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases.
Gonzalez, F. A., Raden, D. L., & Davis, R. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54548-8 · Cited by 446
Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins
Igarashi, K., Kataokat, K., Itoh, K., Hayashi, N., Nishizawa, M., & Yamamoto, M. (1994) · Nature · doi:10.1038/367568a0 · Cited by 443
Kataoka, K., Noda, M., & Nishizawa, M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.700 · Cited by 435
Chemical and molecular regulation of enzymes that detoxify carcinogens.
Prestera, T., Holtzclaw, W. D., Zhang, Y., & Talalay, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2965 · Cited by 421
Nomenclature for N-acetyltransferases
Vatsis, K. P., Weber, W. W., Bell, D. A., Dupret, J., Evans, D. A. P., Grant, D. M., Hein, D. W., Lin, H. J., Meyer, U., Relling, M. V., et al. (1995) · Pharmacogenetics · doi:10.1097/00008571-199502000-00001 · Cited by 412
Prochaska, H. J., & Talalay, P. (1988) · PubMed · Cited by 410
Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes.
Weinshilboum, R. M., Otterness, D. M., Aksoy, I. A., Wood, T. C., Her, C., & Raftogianis, R. B. (1997) · PubMed · Cited by 408
Chen, C., Yu, R., Owuor, E. D., & Tony Kong, A. N. (2000) · Archives of Pharmacal Research · doi:10.1007/bf02975249 · Cited by 403
Self-citationSulfotransferase molecular biology: cDNAs and genes
Weinshilboum, R. M., Otterness, D. M., Aksoy, I. A., Wood, T. C., Her, C., & Raftogianis, R. B. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.1.9034160 · Cited by 369
Li, Y., & Jaiswal, A. K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42151-5 · Cited by 353
Yu, R., Chen, C., Mo, Y.-Y., Hebbar, V., Owuor, E. D., Tan, T.-H., & Kong, A.-N. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004037200 · Cited by 340
Self-citationBenson, A. M., Batzinger, R. P., Ou, S.-Y. L., Bueding, E., Cha, Y., & Talalay, P. (1978) · PubMed · Cited by 337
Mitogen-Activated Protein Kinase Cascades as Regulators of Stress Responses
KARIN, M. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb08987.x · Cited by 326
(1982) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/68.3.493 · Cited by 324
Wattenberg, L. W. (1977) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/58.2.395 · Cited by 303
Peroxisome proliferation and hepatocarcinogenesis
Rao, S. M., & Reddy, J. K. (1987) · Carcinogenesis · doi:10.1093/carcin/8.5.631 · Cited by 302
Yu, R., Lei, W., Mandlekar, S., Weber, M. J., Der, C. J., Wu, J., & Kong, A.-N. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27545 · Cited by 281
Self-citationConjugation Reactions in Drug Metabolism
Kietzmann, M. (1991) · Toxicon · doi:10.1016/0041-0101(91)90312-f · Cited by 256
Moinova, H. R., & Mulcahy, R. T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1109 · Cited by 245
Mechanisms of induction of enzymes that protect against chemical carcinogenesis
Talalay, P. (1989) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(89)90074-5 · Cited by 219
Zhang, Y. S., Kolm, R. H., Mannervik, B., & Talalay, P. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1106 · Cited by 208
Bioactivation of mutagens via sulfation
Glatt, H. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.5.9141497 · Cited by 200
Yu, R., Mandlekar, S., Lei, W., Fahl, W. E., Tan, T.-H., & Kong, A.-N. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2322 · Cited by 196
Self-citationUse of the nuclear receptor PXR to predict drug interactions
Moore, J. T., & Kliewer, S. A. (2000) · Toxicology · doi:10.1016/s0300-483x(00)00300-0 · Cited by 188
Buetler, T. M., Gallagher, E. P., Wang, C. H., Stahl, D. L., Hayes, J. D., & Eaton, D. L. (1995) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1995.1207 · Cited by 184
Yu, R. (1997) · Carcinogenesis · doi:10.1093/carcin/18.2.451 · Cited by 161
Self-citationOkuda, A., Imagawa, M., Maeda, Y., Sakai, M., & Muramatsu, M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84795-6 · Cited by 151
Münzel, P., Schmohl, S., Heel, H., Kälberer, K., Bock-Hennig, B. S., & Bock, K. W. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15251-8 · Cited by 119
Yu, R., Tan, T., & Kong, A.-N. T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.28962 · Cited by 116
Self-citationPhenethyl isothiocyanate, a natural chemopreventive agent, activates c-Jun N-terminal kinase 1.
Yu, R., Jiao, J.-J., Duh, J., Tan, T., & Kong, A.-N. T. (1996) · PubMed · Cited by 110
Self-citationLong, M. J., Prochaska, H. J., & Talalay, P. (1985) · PubMed · Cited by 70
Sparnins, V. L., Ji, C., & Wattenberg, L. W. (1982) · PubMed · Cited by 66
Jun and Fos regulation of NAD(P)H: quinone oxidoreductase gene expression
Jaiswal, A. K. (1994) · Pharmacogenetics · doi:10.1097/00008571-199402000-00001 · Cited by 49
Patten, E. J., & DeLong, M. J. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0422 · Cited by 35
Rushmore, T. H., Pickett, C. B., & Lu, A. (1994) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-78429-3_3 · Cited by 11
Cited by
Cancer chemoprevention with dietary phytochemicals
Surh, Y.-J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1189 · Cited by 2,955
Glutathione: overview of its protective roles, measurement, and biosynthesis
Forman, H. J., Zhang, H., & Rinna, A. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.08.006 · Cited by 2,636
Zhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480
Induction of phase I, II and III drug metabolism/transport by xenobiotics
Xu, C., Li, C. Y.-T., & Kong, A.-N. T. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02977789 · Cited by 1,279
Self-citationCysteine-Mediated Redox Signaling: Chemistry, Biology, and Tools for Discovery
Paulsen, C. E., & Carroll, K. S. (2013) · Chemical Reviews · doi:10.1021/cr300163e · Cited by 1,278
Metadata
- Authors
- Kong, A.-N. T., Owuor, E., Yu, R., Hebbar, V., Chen, C., Hu, R., & Mandlekar, S.
- Venue
- Drug Metabolism Reviews
- Publisher
- Informa UK Limited
- Published
- 2001-01
- Volume
- 33
- Issue
- 3-4
- Pages
- 255-271
- ISSN
- 0360-2532 (ISSN-L)
- 1097-9883
- OpenAlex
- W2046074852
- Cited by
- 316
- References
- 67
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.